Position in MLTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,386,560
+$1,648,206 QoQ
Shares Held
636,187
+10.4% QoQ
Ownership
0.748%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 172 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Derivatives in MLTX
reported options exposure · as of Sep 30, 2025CallValue
$71,700
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. MLTX ranks #87 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in MLTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,386,560 | 636,187 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,738,354 | 576,092 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,579,875 | 802,722 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $71,700 | 10,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $639,363 | 89,172 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $13,452,582 | 344,320 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $541,500 | 10,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $2,584,882 | 51,267 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,539,907 | 216,964 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $512,346 | 10,200 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $1,053,574 | 20,975 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,475,382 | 74,108 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $1,642,608 | 27,200 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $1,740,210 | 30,530 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,812,604 | 192,404 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $750,168 | 35,071 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $147,472 | 28,090 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||